Swi5 interacts with Gal11, Swi2, and Srb4 in vitro. (A) Cell extracts from DY6261 expressing Swi2–Myc, Gal11–Myc, and Srb4–Myc were incubated with Escherichia coli expressed His6–Swi5 derivatives, immunoprecipitated, and probed with anti-Myc antibody. Lane 1, DY6130 (Swi2–Myc) input; Lane 2, DY6145 (Gal11–Myc) input; Lane 3, DY6260 (Srb4–Myc) input; Lane 4, DY6261 (Swi2–Myc, Gal11–Myc, Srb4–Myc) input; Lane 5, His6–Swi5(1–709) immunoprecipitate; Lane 6, His6–Swi5(539–681) immunoprecipitate. (B) GST coprecipitations were performed using purified His6–Swi5(1–709) and the indicated GST fusion proteins and probed with anti-His6 antibody. Lane 1, input His6–Swi5 (20 %); Lane 2, GST–Gal11(1–441) coprecipitate; Lane 3, GST coprecipitate; and Lane 4, GST–Zap coprecipitate. (C) GST coprecipitations using wild-type (WT) or mutant versions of His6–Swi5. Lane 1, input His6–Swi5 (wild type); Lane 2, input His6–Swi5 (V494A); Lane 3, input His6–Swi5 (S497A); Lane 4, eluted His6–Swi5 (wild type); Lane 5, eluted His6–Swi5 (V494A); and Lane 6, eluted His6–Swi5 (S497A).